Latest medical news · page 269

AAFP CME earns special accreditation again—why that matters

FDA expands Rinvoq (upadacitinib) approval

Efficacy supplement (new or revised indication). tablet, extended release, oral. Sponsor: Abbvie

Domino dazzles with another rundown of latest medical research

‘Chaos is an opportunity to do right by the world,’ says FMX speaker

FDA approves Jascayd (nerandomilast)

Original new drug approval. tablet, oral. Sponsor: Boehringer Ingelheim

Surgeon General Murthy emphasizes community in FMX fireside chat

High-Concentration Cannabinoids: Are They Safe?

Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.

Suite of new physician leaders elected at 2025 Congress of Delegates

Congress of Delegates adopts measures to strengthen physicians and patient health

FDA expands Zoryve (roflumilast) approval

Efficacy supplement (new or revised indication). cream, topical. Sponsor: Arcutis

FDA expands Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Genentech Inc

FDA expands Tecentriq (atezolizumab) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Genentech Inc

Academy objects to visa changes limiting primary care workforce

Make the most out of FMX

Federal government shutdown: What family physicians need to know—and do

Episode 238 -- September 2025 -- Part 2 AFP: American Family Physician

Lymphadenopathy (1:30), galantamine for dementia (5:30), parenteral agents for migraines (7:30), EpiSwitch prostate cancer screening test (10:40), vitamin B12 deficiency (14:00), and fezolinetant for menopause (17:40).

FDA expands Tremfya (guselkumab) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Janssen Biotech

FDA expands Tremfya (guselkumab) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Janssen Biotech

FDA expands Tremfya (guselkumab) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Janssen Biotech

FDA approves Keytruda Qlex (pembrolizumab, berahyaluronidase alfa-pmph)

Original biologic license approval. injectable, injection. Sponsor: Merck Sharp Dohme

FDA approves Keytruda Qlex (pembrolizumab, berahyaluronidase alfa-pmph)

Original biologic license approval. injectable, injection. Sponsor: Merck Sharp Dohme

FDA expands Opzelura (ruxolitinib phosphate) approval

Efficacy supplement (new or revised indication). cream, topical. Sponsor: Incyte Corp

Level 1 - Oropouche in the Americas

Areas in several countries are reporting a low number of cases of Oropouche. Oropouche is spread primarily through the bites of infected midges (small flies) and mosquitoes. Country List : Brazil, Peru, Cuba, Panama

Episode 66 - Diamantis Plachouras - The Silent Spread - Europe’s C. auris Challenge

In this episode of ECDC On Air , we talk to ECDC's Head of Section - Antimicrobial Resistance and Healthcare-Associated Infections - Dr Diamantis Plachouras , who explains the rising threat of the drug-resistant fungus Candidozyma (Candida) auris . Discovered only in 2009, C. auris has become a serious problem in European hospitals - spreading between patients, persisting on surfaces and equipment, and resisting multiple antifungal treatments. Diamantis outlines how infections develop, why treatment is so difficult, and what the latest ECDC survey shows: over 4,000 EU/EEA cases since 2013…